Hetero Labs Limited Atovaquone Export Data — India (DGFT 2022–2026)

Name: Hetero Labs Limited Atovaquone Export Records India — #3 Exporter, 137 Shipments, $6.8M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Atovaquone

India Pharmaceutical Trade Intelligence

$990.7M17 Suppliers21 CountriesHS 30049099

ExportsIndia → HUNGARY93.7%India → UNITED STATES5.0%

ImportsGERMANY → India$53.1K UNITED STATES → India$34.3K

#1 Supplier: MYLAN LABORATORIES #1 Buyer: MYLAN HUNGARY

Hetero Labs Limited — Atovaquone Exporter #3 | $6.8M Trade Value | TransData Nexus | TransData Nexus

Hetero Labs Limited — Atovaquone Exporter Profile

Indian Pharmaceutical Exporter · #3 for Atovaquone · $6.8M export value · DGFT Verified

Hetero Labs Limited is the #3 Indian exporter of Atovaquone with $6.8M in export value and 137 verified shipments. Hetero Labs Limited holds a 0.7% market share in Atovaquone exports across 4 countries. The company exports 46 pharmaceutical products worth $319.3M across 18 therapeutic categories.

Hetero Labs Limited — Atovaquone Export Profile: Buyers & Destinations

Hetero Labs Limited Atovaquone export treemap — buyers and destination countries | TransData Nexus

Where Does Hetero Labs Limited Export Atovaquone?

Country	Value	Shipments	Share
UNITED STATES	$6.2M	124	94.7%
NETHERLANDS	$165.0K	7	2.5%
UNITED KINGDOM	$104.6K	3	1.6%
UNITED STATES OF AMERICA	$50.0K	1	0.8%

Who Are the Top Buyers of Atovaquone from Hetero Labs Limited?

Buyer	Country	Value	Orders
TO THE ORDER OF....	UNITED STATES	$2.4M	49
TO THE ORDER OF	UNITED STATES	$2.4M	48
CAMBER PHARMACEUTICALS INC	UNITED STATES	$400.0K	8
TO THE ORDER	UNITED STATES	$350.0K	7
TO THE ORDER OF :	UNITED STATES	$200.0K	4
M STO THE ORDER OFCAMBER PHARMACEUTICALS INC	UNITED STATES	$150.0K	3
XXAROXXPHAXXA GXXH	NETHERLANDS	$117.6K	5
XXAROXXLIMXXED	UNITED KINGDOM	$104.6K	3
TO THE ORDER OF.	UNITED STATES	$50.0K	1
CAMBER PHARMACEUTICALS, INC.	UNITED STATES	$50.0K	1

Hetero Labs Limited supplies Atovaquone to 15 buyers globally. The largest buyer is TO THE ORDER OF.... (UNITED STATES), followed by TO THE ORDER OF (UNITED STATES) and CAMBER PHARMACEUTICALS INC (UNITED STATES). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Atovaquone Formulations Does Hetero Labs Limited Export?

Product Description / Formulation	Value	Shipments
ATOVAQUONE ORAL SUSPENSION 750MG/5ML SOL	$1.8M	36
ATOVAQUONE 750MG/5ML ORAL SOLUTION	$1.2M	25
ATOVAQUONE ORAL SOLUTION	$1.1M	21
ATOVAQUONE LIQUID SYRUP	$650.0K	13
ATOVAQUONE 750MG/5ML ORAL SOLUTION 210ML	$250.0K	5
ATOVAQUONE ORAL SOLUTION 210ML	$250.0K	5
ATOVAQUONE/PROGUANIL 250/100MG TABLETS	$202.8K	5
ATOVAQUONE ORAL SOLUTIONNOS	$200.0K	4
ATOVAQUONE ORAL SUSPENSION SOLUTION	$100.0K	2
ATOVAQUONE 750MG/5ML ORAL SOLUTION, 210ML PACK	$100.0K	2

Hetero Labs Limited exports 29 distinct Atovaquone formulations including tablets, capsules, syrups, and combination drugs. The top formulation is ATOVAQUONE ORAL SUSPENSION 750MG/5ML SOL with 36 shipments worth $1.8M. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.

How Does Hetero Labs Limited Compare to Nearest Atovaquone Exporters?

Exporters ranked immediately above and below #3 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
2	GLENMARK PHARMACEUTICALS LIMITED	$8.8M	177	11	$50.0K
3	HETERO LABS LIMITED ★	$6.8M	137	4	$50.0K
1	MYLAN LABORATORIES LIMITED	$2.9M	58	5	$50.0K
4	LUPIN LIMITED	$700.0K	14	1	$50.0K

Hetero Labs Limited ranks #3 among 17 Indian Atovaquone exporters. Average shipment value of $50.0K compared to the market average of $1.2M. The closest competitors by value are GLENMARK PHARMACEUTICALS LIMITED and MYLAN LABORATORIES LIMITED.

Which Indian Ports Ship Atovaquone Exports?

Port	Shipments	% Share
SAHAR AIR	80	18.3%
SAHAR AIR CARGO ACC (INBOM4)	62	14.2%
HYDERABAD ICD (INSNF6)	42	9.6%
NHAVA SHEVA SEA (INNSA1)	33	7.6%
HYDERABAD AIR	27	6.2%
JNPT	26	5.9%
DELHI AIR	26	5.9%
DELHI AIR CARGO ACC (INDEL4)	22	5.0%

Geopolitical & Trade Policy Impact on Hetero Labs Limited's Atovaquone Exports

The current geopolitical climate presents both challenges and opportunities for Hetero Labs Limited. The Israel-Iran tensions have led to increased risks in the Red Sea shipping routes, prompting major shipping lines to implement 'Emergency Risk Surcharges' ranging from $250 to $500 per TEU. This escalation in shipping costs directly impacts Indian pharmaceutical exporters like Hetero, potentially eroding profit margins and necessitating strategic adjustments in logistics and pricing strategies.

Conversely, the U.S.-China trade tensions have created openings for Indian pharmaceutical companies. The U.S. has imposed tariffs as high as 245% on APIs from certain countries, leading to a reshoring of pharmaceutical manufacturing. Indian firms, including Hetero, have responded by investing in U.S. facilities, with outbound foreign direct investment estimated between $500-700 million during the partial FY 2025-26. This strategic move not only circumvents tariffs but also strengthens Hetero's presence in the lucrative U.S. market.

The recent India-European Union Free Trade Agreement (FTA), concluded in January 2026, eliminates tariffs on Indian pharmaceuticals entering the EU. This development enhances Hetero's competitiveness in the European market, providing a significant boost to its export potential. However, compliance with the EU's Falsified Medicines Directive remains imperative, necessitating stringent quality controls and traceability measures to maintain market access.

Hetero Labs Limited — Regulatory Compliance & Quality Standards

Regulatory compliance is paramount for Hetero's sustained success in international markets. In October 2025, the U.S. Food and Drug Administration (FDA) issued a Form 483 to Hetero's Nakkapalli facility in Andhra Pradesh, citing six major compliance lapses, including quality control deficiencies and improper documentation practices. Such observations can jeopardize Hetero's ability to supply APIs and antiretroviral drugs to the U.S. market, underscoring the critical need for rigorous adherence to Good Manufacturing Practices (GMP) and prompt corrective actions to address regulatory concerns.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Atovaquone shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Hetero Labs Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 137 individual customs records matching Hetero Labs Limited exporting Atovaquone, covering 29 formulations to 5 countries via 15 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 21+ countries, 71+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Atovaquone

Atovaquone

Hetero Labs Limited — Atovaquone Exporter Profile

Hetero Labs Limited — Atovaquone Export Profile: Buyers & Destinations

Where Does Hetero Labs Limited Export Atovaquone?

Who Are the Top Buyers of Atovaquone from Hetero Labs Limited?

What Is India's Total Atovaquone Export Value and How Much Does Hetero Labs Limited Contribute?

What Is the Average Shipment Value for Hetero Labs Limited's Atovaquone Exports?

How Does Hetero Labs Limited Compare to Other Indian Atovaquone Exporters?

What Atovaquone Formulations Does Hetero Labs Limited Export?

Regulatory Requirements: Exporting Atovaquone to Key Markets

United States — FDA

United Kingdom — MHRA

How Does Hetero Labs Limited Compare to Nearest Atovaquone Exporters?

Which Indian Ports Ship Atovaquone Exports?

Atovaquone — Export Intelligence Video

Geopolitical & Trade Policy Impact on Hetero Labs Limited's Atovaquone Exports

Hetero Labs Limited — Regulatory Compliance & Quality Standards

About Hetero Labs Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Atovaquone Export Data from Hetero Labs Limited

Atovaquone Stats

Company Overview

Top Products by Hetero Labs Limited

Related Analysis

Need Detailed Export Data?

Data Source